Role of rosuvastatin and pitavastatin in alleviating diabetic cardiomyopathy in rats: Targeting of RISK, NF-κB/ NLRP3 inflammasome and TLR4/ NF-κB signaling cascades.

Diabetic cardiomyopathy (DCM) is a serious outcome of type II diabetes mellitus (T2DM) and a key contributor to high morbidity and death in diabetic individuals. The current research is intended to elucidate and compare the therapeutic benefits of rosuvastatin (RVS) and pitavastatin (PTS) in mitigat...

Full description

Saved in:
Bibliographic Details
Main Authors: Dalia O Saleh, Nesma M E Abo El Nasr, Marawan A Elbaset, Marwa E Shabana, Tuba Esatbeyoglu, Sherif M Afifi, Ingy M Hashad
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0325767
Tags: Add Tag
No Tags, Be the first to tag this record!